Back to top
more

Boston Scientific (BSX)

(Delayed Data from NYSE)

$87.59 USD

87.59
5,119,705

-1.18 (-1.33%)

Updated Nov 14, 2024 04:00 PM ET

After-Market: $87.59 0.00 (0.00%) 7:58 PM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy24.10%
2Buy17.80%
3Hold9.50%
4Sell2.70%
5Strong Sell2.70%
S&P50011.20%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value C Growth F Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 34% (84 out of 250)

Industry: Medical - Products

Zacks News

TMO Stock Gains From Innovation Amid Macroeconomic Issues

Thermo Fisher's business strategy involves expansion through strategic acquisition of technologies and businesses that boost its existing products and services.

RMD Stock Likely to Gain From Enhanced Digital Sleep Health Solutions

ResMed introduces digital and personalized solutions designed to improve sleep health.

Urmimala Biswas headshot

3 MedTech Stocks to Buy as Monetary Policy Eases

Here, we pick three MedTech stocks, VCYT, BSX and PAHC, which are anticipated to gain strongly in 2024 from the loosening of monetary policy.

Positive Trial Outcome for PulseSelect PFA Likely to Boost MDT Stock

Medtronic presents new clinical data on the PulseSelect PFA System and marks its launch in Japan.

BSX Stock Gains From FARAPULSE PFA's PMDA Approval in Japan

Boston Scientific achieves PMDA approval for its FARAPULSE PFA System in Japan. The company expects to launch the system in the country in the upcoming weeks.

Reasons to Retain DENTSPLY SIRONA Stock in Your Portfolio Now

XRAY continues to gain traction from a robust product portfolio. However, macroeconomic factors like weakened global demand, rising costs and forex woes persist.

Zacks.com featured highlights General Motors, Boston Scientific and Assurant

General Motors, Boston Scientific and Assurant have been highlighted in this Screen of The Week article.

HAE vs. BSX: Which Stock Is the Better Value Option?

HAE vs. BSX: Which Stock Is the Better Value Option?

Is HOLX Stock a Smart Hold for Your Portfolio Right Now?

Hologic's strength in Molecular Diagnostics is highly promising. Yet, macroeconomic uncertainties can pose headwinds for its operations.

QGEN Stock to Gain From New IVDR Win for QIAstat-Dx Systems and Panels

QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays.

Boston Scientific (BSX) Stock Declines While Market Improves: Some Information for Investors

Boston Scientific (BSX) closed at $83.08 in the latest trading session, marking a -0.5% move from the prior day.

Tirthankar Chakraborty headshot

The S&P 500 to Hit 6,000 Soon? Buy 3 Momentum Stocks Now

S&P 500 stocks such as General Motors, Boston Scientific, and Assurant have been selected as the momentum picks for the day using the Driehaus strategy.

MDT Stock Might Gain From Expanded AiBLE Ecosystem and New Partnership

Medtronic expands AiBLE spine surgery ecosystem with new technologies and a partnership with Siemens Healthineers.

Here's Why You Should Add HAE Stock in Your Portfolio Now

Strong prospects of the Plasma franchise and favorable solvency bode well for Haemonetics.

Tirthankar Chakraborty headshot

NVIDIA & 2 Other S&P 500 Stocks Show Strong Earnings Growth

S&P 500 stocks such as NVIDIA, Boston Scientific and American Water Works are, currently, exhibiting superb earnings growth.

VEEV Stock Down Despite Expansion of Vault QMS to Boost Patient Safety

Veeva Systems' addition of new capabilities is likely to improve the timeliness and accuracy of field actions to ensure product quality and patient safety.

Zacks Industry Outlook Highlights Boston Scientific, Baxter International, Haemonetics and Phibro Animal Health

Boston Scientific, Baxter International, Haemonetics and Phibro Animal Health are part of the Zacks Industry Outlook article.

Exclusive Partnership With Pair Eyewear Likely to Support EYE Stock

National Vision's America's Best stores become the exclusive retail partner of Pair Eyewear.

Should You Continue to Retain LH Stock in Your Portfolio?

Labcorp's expanding testing solutions in high-growth areas, partnerships and focus on operational efficiency instill optimism.

Axonics Stock Rises on Favorable Verdict in Patent Case With Medtronic

AXNX stock continues to gain following a favorable court ruling last week in a patent litigation with Medtronic.

Reasons to Retain Intuitive Surgical Stock in Your Portfolio Now

Intuitive Surgical (ISRG) continues to raise optimism among investors owing to its strength in robotics.

Senseonics Stock Down Despite New FDA Approval for Eversense 365

SENS' latest regulatory clearance is likely to simplify diabetes management with the help of a long-lasting CGM system.

LH Stock Likely to Gain From the Molecular Bioanalytical Lab Expansion

Labcorp expands the molecular bioanalytical laboratory in Greenfield, IN.

Reasons to Retain Alcon Stock in Your Portfolio for Now

Strong growth in the Surgical and Vision Care businesses raises investors' optimism for ALC.

Indrajit Bandyopadhyay headshot

4 Medical Product Stocks to Buy From a Prospective Industry

Ongoing rise in demand for medical procedures and cost-cutting initiatives should support the Zacks Medical-Products industry. BSX, BAX, HAE and PAHC are well-poised to gain from the favorable factors.